Updated Results from the Phase II Study of Hyper-CVAD in Combination with Ofatumumab as Frontline Therapy for Adults with CD20 Positive (CD20+) ALL

Publication date: September 2016 Source:Clinical Lymphoma Myeloma and Leukemia, Volume 16, Supplement 2 Author(s): Ghayas Issa, Hagop Kantarjian, Farhad Ravandi, Deborah Thomas, Maria Khouri, Guillermo Garcia Manero, Rebecca Garris, Jorge Cortes, Nicholas Short, Koji Sasaki, Heather Schroeder, Tapan Kadia, Srdan Verstovsek, Naval Daver, Nitin Jain, Marina Konopleva, Susan O'Brien, Elias Jabbour

Source: Clinical Lymphoma Myeloma and Leukemia - September 20, 2016 Category: Cancer & Oncology Source Type: research